Abstract: Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent. The sample inlet port is connected to the reaction area, and the coagulation reagent comprises blood plasma deficient in the coagulation factor for which activity is to be measured, an ionic citrate source an ionic calcium source, and either one or more coagulation contact phase activator reagents and phospholipids or a mixture of tissue factor and phospholipids. The disclosure further relates to in vitro methods for measuring an activity of a coagulation factor.

Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection. The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Compositions and associated methods of preparing placental tissue products/compositions are disclosed together with methods of utilizing the placental tissue composition for delivery of a therapeutic agent.

Abstract: Disclosed herein are natural product compositions for treating ADHD and related disorders.

Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms selenium, chromium, and molybdenum in c combination with a fish oil.

Abstract: Embodiments of the invention relate to the microbial production of polyhydroxyalkanoic acids, or polyhydroxyalkanoates (PHA), from substrates which cannot be used as a source of carbon and/or energy for microbial growth or PHA synthesis and which have microbial and environmental toxicity. According to one embodiment of the invention, a process for the production of PHA is provided wherein an enzyme such as methane monooxygenase is used to convert volatile organic compounds into PHA through the use of microorganisms that are unable to use volatile organic compounds as a source of carbon for growth or PHA production.

Abstract: The present invention relates to a powdered composition obtained from saffron stigmas characterized in that it comprises from 0.03% to 1% dry weight of safranal; and at least 3.48% dry weight of crocins that encompasses the various trans-crocin-4 (major isomer), trans-crocin-3, trans-crocin-2?, cis-crocin-4, trans-crocin-2, trans-crocin-1 isomers and any of their mixtures.

Abstract: The present invention relates to the preparation of an extract of the crustacean Artemia salina and to the use thereof to treat diseases of the ocular surface. The invention describes the application of the extract mainly by means of soaps, eyedrops, eye solutions, eye washes, aerosols, in the presence of unguents, creams, gels or contact lenses, inter alia. The application of the Artemia salina extract is efficient for treating pathologies consistent with ocular dryness (dry eye) and the manifestations thereof such as the appearance of injuries or ulcers on the ocular surface or infections caused by microorganisms and associated with dry eye, also on of the ocular surface.

Abstract: The present invention provides a fermented product obtained by fermenting honey and camomile or a treated product thereof with Lactobacillus kunkeei.

Abstract: A water resistant enhanced wound healing film includes components by mass volume concentration of: 5-10 mg/L of ultra-fine eggshell powder, 50-500 mg/L of ultramicroshell membrane powder or shell membrane soluble protein, 5-30 mg/L of lysozyme, 5-10 mg/L of chitosan, 0.05-5 mg/L of glycerin, and 0.1-5 mg/L of polymer polysaccharide. Also, a preparation method of the water resistant enhanced wound healing film is disclosed. The whole raw materials of the present invention are non-toxic and have good biocompatibility; the raw materials include eggshell, shell membrane and soluble mixed protein thereof, and lysozyme in residual egg white. In the present invention, various components of the eggshell waste are sufficiently used. The wound healing film has good water resistance, mechanical properties, antibacterial activity and protein absorption capacity, and low degradation rate.

Abstract: The present invention discloses an Elaeagnus angustifolia yoghourt and a manufacturing method thereof. The yoghourt is manufactured by taking fresh milk, white granulated sugar, Elaeagnus angustifolia, apple pear juice and Elaeagnus angustifolia honey drink as main ingredients. The Elaeagnus angustifolia yoghourt is not only delicate in product taste and unique in flavor but also rich in nutrition and has effects of nourishing yang and moistening dryness and invigorating spleen and strengthening stomach.

Abstract: A system and method for antibiotic susceptibility testing efficiently determines whether bacteria are alive or have been killed by antibiotic treatment. The antibiotic susceptibility testing device includes at least one reservoir into which a bacteria solution is introduced and a microfluidic channel connected to the reservoir, wherein the cross-sectional size of the microfluidic channel is selected to be comparable to the size of the bacterium to be tested. Furthermore, the electrical resistance or voltage signal across the microchannel is monitored as bacteria swim into and out of the channel. Alternatively, a small population of bacteria can be immobilized in the microchannel. The resistance or voltage signal fluctuates when the bacteria are alive and moving in and out of the channel or wiggling on the microchannel walls. If the bacteria are dead, they have limited motility and the signal fluctuations are significantly smaller.

Abstract: Provided are a nanocomposite including a nano-drug delivery system; and a ginseng extract or a ginsenoside isolated therefrom, and a preparation method thereof, in which the nanocomposite may be used for the prevention or treatment of cancer and inflammatory diseases. The metal nanocomposite of the present invention may be prepared in a uniform size without using an additional reducing agent or stabilizing agent in a significantly shortened time, as compared with known metal nanoparticles. Further, since the metal nanocomposite has high solubility in water and high targeting ability for cancer cells, it can be advantageously developed as drugs. Further, the metal nanocomposite exhibits high anti-cancer and anti-inflammatory activities, and thus may be usefully applied to prevention or treatment of cancer and inflammatory diseases.

Abstract: The present disclosure provides methods for the treatment of autism spectrum disorders. More particularly, the present disclosure relates to methods of using cord blood for the treatment of autism spectrum disorders.

Abstract: The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment.

Abstract: A method for at least one of whitening skin, improving skin condition, protecting skin and inhibiting skin aging is provided, wherein the method comprises administering to a subject in need an effective amount of a coffee pulp extract. A method for at least one of repairing skin tissues, preventing skin disease, and treating skin disease is also provided, wherein the method comprises administering to a subject in need an effective amount of a coffee pulp extract.

Abstract: The invention includes compositions and methods to rapidly isolate and culture cells that are potent for use in adoptive immunotherapy. In one embodiment, the isolated cells of the invention are tumor infiltrating lymphocytes (TIL) that express CD137 (also known as 4-1BB and TNFSFR9).

Abstract: The present invention relates to the provision of a bactericidal, antiviral preparation obtained from the process of forming a homogeneous solution mixture by mixing an emulsion of butter extract. The method of making this composition is a systematic technical solution to create a multi-polar substance that can dissolve easily in water but still has to be soluble in oil, along with an osmotic substance that dissolves the lipid layer capsid inactivates the virus. Compositions obtained from this method have the effect of bactericidal, antiviral, environmental treatment—deodorizing—anti-pollution in order to meet the urgent needs of people, society and environment.

Abstract: The present invention provides improved methods, facilities and systems for parallel processing of biological cellular samples in an efficient and scalable manner. The invention enables parallel processing of biological cellular samples, such as patient samples, in a space and time efficient fashion. The methods, facilities and systems of the invention find particular utility in processing patient samples for use in cell therapy.

Abstract: Thin film devices, e.g., multilayer thin film devices, that encapsulate cells for transplantation into a subject are provided. Also provided are methods of using and methods of preparing the subject devices. The thin film devices include a first porous polymer layer and a second porous polymer layer that define a lumen therebetween and encapsulate a population of cells within the lumen. The thin film devices can promote vascularization into the lumen of the device via the pores in the first polymer layer and/or second polymer layer; limit foreign body response to the device; limit ingress of cells, immunoglobulins, and cytokines into the lumen via the first and the second polymer layers; and release from the first polymer layer and/or the second polymer layer molecules secreted by the population of cells.